Cetuximab and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

NCT00101192 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

76

Enrollment

NETWORK

Sponsor class

Conditions

Cervical Cancer

Interventions

BIOLOGICAL: cetuximab
DRUG: cisplatin

Sponsor

Gynecologic Oncology Group

Collaborators

[object Object]
[object Object]